Source: http://i-mak.squarespace.com/pharma-patent-decisions/
Timestamp: 2017-11-21 17:06:53
Document Index: 763624054

Matched Legal Cases: ['Application No. 1878', 'Application No. 628', 'Application No. 474', 'Application No. 2488', 'Application No. 2648', 'Application No. 3513', 'Application No. 1647', 'Application No. 1003', 'Application No. 237', 'Application No. 3383', 'Application No. 3764', 'Application No. 3598', 'Application No. 2145', 'Application No. 396', 'Application No. 190', 'Application No. 537']

Application for a liquid fill composition for a soft capsule dosage form comprising vinorelbine (used as an anti-mitotic chemotherapy drug).
Shanghai Huayi Bio Lab, Application No. 1878/DELNP/2003, Delhi Patent Office (2009)
The decision deals with whether an application which does not specify that it is mailbox application can be divided out to overcome such an objection.
Boehringer Ingelheim Pharma, Application No. 628/DELNP/2003, Delhi Patent Office (2009)
An application for an inhalable formulation of solution containing tiotropium salt.
Hoffman La Roche AG (Application No. 474/MAS/1996) v Wockhardt Ltd, Chennai Patent Office (2009)
Pre-grant opposition against a pharmaceutical composition for the oral administration of glimepiride (markerted as Amaryl for diabetes) and thiazolidinedione.
AstraZeneca AB, Application No. 2488/DELNP/2004, Delhi Patent Office (2009)
Application for a crystalline form of the compound ZD 1839, otherwise known as gefitinib (marketed as Iressa) to treat non-small cell lung cancer.
Algorx Pharmaceuticals Inc, Application No. 2648/DELNP/2005, Delhi Patent Office (2009)
Application for a mixture of enantiomers of milnacipran (marketed as Ixel or Savella) and their pharmaceutically acceptable salts.
Advanced Inhalation Research Inc, Application No. 3513/DELNP/2005, Delhi Patent Office (2009)
Pre-grant opposition against an antibiotic treatment combining cefepime and amikacin.
Tibotec Pharmaceuticals (Application No. 1647/DELNP/2000) v Cipla Ltd, Delhi Patent Office (2009)
Pre-grant opposition against Tibotec's application for a combination of protease inhibitors e.g. ritonavir ) and cytochome P450 inhibitors. The decision also deals with when an application is considered to have been granted under the Act for the purpose of a pre-grant opposition to be admitted.
Les Laboratories Servier, Application No. 1003/DEL/2006, Delhi Patent Office (2009)
Application for a pharmaceutical compositon commprising agomelatine, its hydrates and crystalline forms and pharmaceutically acceptable acid addition salts for use in the treatment of bipolar disorders. The application also claimed the synergystic combination of agomelatine and a thymoregulatory agent.
Application by Bayer for quineolinecarboxylic acids and their derivatives. The decision deals with whether an application which does not specify that it is mailbox application can be divided out to overcome such an objection.
Sanofi Synthelabo, Application No. 237/DEL/2001, Delhi Patent Office (2009)
Application by Sanofi for a pharmaceutical product patent. The decision deals with whether an application which does not specify that it is mailbox application can be divided out to overcome such an objection.
Gilead Sciences Inc (Application No. 3383/DELNP/2005) v Cipla Ltd, Delhi Patent Office (2009)
Application for the use of lupin conglutin for the treatment of type-II diabetes.
Schering AG (Application No. 3764/DELNP/2005) v Sun Pharmaceuticals Industries Ltd, Delhi Patent Office (2009)
Pre-grant opposition by Cipla against Gilead's application for an ester derivative of tenofovir disoproxil.
Tibotec Pharmaceuticals Ltd (Application No. 3598/DELNP/2004) v Cipla Ltd, Delhi Patent Office
Decision on the writ petiton of Bayer requesting its granted patent for sorafenib be linked to the marketing approval process for Cipla's generic version.
Novartis AG v Union of India & Others, Intellectual Property Appellate Board (2009)
Pre-grant opposition by Sun Pharmaceuticals and others against Novartis's application for the alpha-crystalline form of imatinib mesylate (Glivec).
AstraZeneca AB, Application No. 2145/DELNP/2004, Delhi Patent Office (2009)
Gilead Sciences Inc (Application No. 396/DEL/1996) v Cipla Ltd, Delhi Patent Office (2009)
Pre-grant opposition by Cipla against Gilead's patent application for oseltamivir (marketed as Tamiflu), used to treat flu viruses.
Pre-grant opposition Ranbaxy against Pfizer's application for a controlled release bead of tolterodine, a metabolite of tolterodine or its pharmaceutically acceptable salts. Tolterodine (marketed as Detrol or Detrutisol) is a antimuscarinic drug used to treat urinary incontinence.
Sugen Inc and Pharmacia Upjohn (Patent No. 209251/Application No. IN/PCT/2002/00785/DEL) v Natco Pharma Ltd, Delhi Patent Office (2008)
Pre-grant opposition by Torrent against Astra's application for a magnesium salt of S-omeprazole trihydrate.
Eli Lilly & Co (Application No. IN/PCT/2000/00119) v USV Ltd (2007)
Pre-grant opposition by Ranbaxy against Pfizer's application for a capsule or tablet capable of providing controlled release of tolterodine or a pharmaceutically acceptable salt to achieve constant serum level of the active moiety. Tolterodine (marketed as Detrol or Detrutisol) is a antimuscarinic drug used to treat urinary incontinence.
F.Hoffmann La Roche AG (Application No. 190/MAS/1998) v Ranbaxy Laboratories, Chennai Patent Office (2007)
Pre-grant opposition by Ranbaxy against Roche's application for a pharmaceutical composition, comprising a plurality of particles having an average diameter from 0.25mm to 2mm, each particle comprising tetrahydrolipstatin and various excipients. Also known as orlistat (marketed as Xenical by Roche), tetrahydrolipstatin is a drug used to treat obesity.
Pfizer Products Inc (Application No. 537/DEL/1996) v Natco Pharma Ltd, Delhi Patent Office (2007)
Pre-grant opposition by Cipla and Cancer Patients group against Novartis's application for beta crystalline form of imatinib mesylate (marketed as Glivec) to treat chronic myeloid leukemia.
Wockhardt Ltd v Hetero Drugs Ltd & Another, High Court of Madras (2006)